Liraglutide therapy in Prader-Willi syndrome

Diabet Med. 2011 Jun;28(6):755-6. doi: 10.1111/j.1464-5491.2011.03280.x.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Drug Therapy, Combination
  • Female
  • Glucagon-Like Peptide 1 / analogs & derivatives*
  • Glucagon-Like Peptide 1 / therapeutic use*
  • Humans
  • Liraglutide
  • Metformin / therapeutic use*
  • Obesity, Morbid / drug therapy*
  • Obesity, Morbid / metabolism
  • Prader-Willi Syndrome / drug therapy*
  • Prader-Willi Syndrome / metabolism
  • Treatment Outcome

Substances

  • Liraglutide
  • Glucagon-Like Peptide 1
  • Metformin